The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

KIDCARES10, First Patient Treated in Pediatric PI Study
Thirty patients aged 2 to 17yo to be enrolled over five European countries
Read all
Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update
KEDRAB® is now the first and only HRIG available in the U.S. to be clinically studied in children
Read all
World Blood Donor Day 2021, Kedrion pays tribute to the world of donors
A special edition for Italy, which is hosting the global World Blood Donor Day event
Read all